Question 1

How do cytokine receptors become activated in the JAK-STAT pathway?

Accepted Answer

Cytokine receptors are activated when small signaling molecules called cytokines bind to their extracellular domains. This binding causes the receptors to dimerize, bringing two tightly bound Janus kinase (JAK) proteins closer together at the cytosolic tail. The proximity allows JAKs to trans-phosphorylate and activate each other, initiating the signaling cascade.

Question 2

What role do STAT proteins play after JAK phosphorylation?

Accepted Answer

Once JAKs phosphorylate the tyrosine residues on the cytoplasmic tail of cytokine receptors, STAT proteins bind via their SH2 domain to these phosphotyrosine sites. JAKs then phosphorylate STAT's C-terminal tyrosine residue, causing a conformational change. Phosphorylated STATs dissociate from the receptor, dimerize with other STAT monomers, and translocate to the nucleus to bind regulatory gene sequences and initiate transcription.

Question 3

How does the JAK-STAT pathway shut down after an appropriate cellular response?

Accepted Answer

The JAK-STAT pathway is regulated by three mechanisms. Suppressors of cytokine signaling (SOCS) proteins bind phosphotyrosines and recruit E3 ubiquitin ligases to degrade JAKs. Protein tyrosine phosphatases like SHP1 dephosphorylate and inactivate JAKs. Protein inhibitors of activated STATs (PIAS) prevent activated STAT dimers from binding DNA, effectively terminating the signaling cascade.

Question 4

What are the seven types of STAT transcription factors in mammalian cells?

Accepted Answer

Seven STAT transcription factors are associated with mammalian cellular responses: STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6. Each STAT consists of an N-terminal DNA-binding domain, an SH2 domain, and a C-terminal domain with a conserved tyrosine residue. Unphosphorylated STATs remain inactive in the cytoplasm until activated by JAK phosphorylation.

Question 5

How does erythropoietin signaling promote red blood cell production?

Accepted Answer

Erythropoietin (Epo) binds to the EpoR receptor on erythroid progenitor cells, activating the STAT5 protein through the JAK-STAT pathway. Activated STAT5 induces expression of Bcl-xL, an anti-apoptotic protein that prevents programmed cell death. This allows erythroid progenitor cells to survive and undergo irreversible differentiation to produce mature red blood cells.

Question 6

What other signaling pathways can be activated by JAK kinases?

Accepted Answer

Beyond activating STATs, activated JAKs serve as binding sites for SH2 domain-containing proteins like phosphatidylinositol-3-kinase (PI3K) and adaptor proteins like Grb2-SOS. PI3K binding activates the PI3K/mTOR/AKT signaling pathway, while Grb2-SOS binding promotes the Ras-MAPK signaling cascade, allowing JAK-STAT to integrate with multiple cellular response networks.

Question 7

What structural features enable STAT dimerization and nuclear translocation?

Accepted Answer

Phosphorylated STAT monomers dimerize via their SH2 domains, which recognize and bind phosphotyrosine residues on partner STAT molecules. Dimerization exposes the nuclear-localization signal (NLS), a conserved sequence that directs the STAT dimer into the nucleus. Once in the nucleus, STAT dimers bind specific cis-regulatory sequences of target genes to initiate transcription.

JAK-STAT Sinyal Yolu

Browse More Videos